Change of manufacturer for topical erectile dysfunction drug

Vitaros (alprostadil) is an option for patients with conditions that preclude them from using oral erectile dysfunction treatments.
Vitaros (alprostadil) is an option for patients with conditions that preclude them from using oral erectile dysfunction treatments.

The erectile dysfunction treatment Vitaros (alprostadil) is now available from Ferring.

Originally launched in 2014 by Takeda, the topical cream incorporates a skin-permeation enhancer that aids absorption of alprostadil through the glans of the penis. After application, the onset of action is within five to 30 minutes and the effect lasts for 1-2 hours after dosing.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more